Back to Search
RICHARD KAST, M.D.
Psychiatry Physician
NPI: 1235233644IndividualAccepts Medicare
Specialties, Licenses & Credentials
Psychiatry PhysicianPrimary
Psychiatry & Neurology — Psychiatry
Code: 2084P0800X
042-0008320(VT)
Education
OTHER
Class of 1978
Research & Publications (20)
Use of FDA approved methamphetamine to allow adjunctive use of methylnaltrexone to mediate core anti-growth factor signaling effects in glioblastoma.
PMID 19322519·J Neurooncol·2009
6-review
Endothelin-1 inhibition by ambrisentan as a potential treatment adjunct after debulking surgery in epithelial ovarian cancer.
PMID 19544975·Oncol Res·2009
6-review
Trazodone generates m-CPP: in 2008 risks from m-CPP might outweigh benefits of trazodone.
PMID 19384678·World J Biol Psychiatry·2009
7-preclinical
Suppressing glioblastoma stem cell function by aldehyde dehydrogenase inhibition with chloramphenicol or disulfiram as a new treatment adjunct: an hypothesis.
PMID 19500061·Curr Stem Cell Res Ther·2009
7-preclinical
How lithium treatment generates neutrophilia by enhancing phosphorylation of GSK-3, increasing HIF-1 levels and how this path is important during engraftment.
PMID 17906701·Bone Marrow Transplant·2008
7-preclinical
Potential for all-trans retinoic acid (tretinoin) to enhance interferon-alpha treatment response in chronic myelogenous leukemia, melanoma, myeloma and renal cell carcinoma.
PMID 18769114·Cancer Biol Ther·2008
6-review
Doxorubicin cardiomyopathy via TLR-2 stimulation: potential for prevention using current anti-retroviral inhibitors such as ritonavir and nelfinavir.
PMID 17351982·Hematol Oncol·2007
6-review
Consideration of use of phenothiazines in particular trifluorperazine for epidermal growth factor receptor associated cancers.
PMID 17448610·Med Hypotheses·2007
8-other
Cancer chemotherapy and cachexia: mirtazapine and olanzapine are 5-HT3 antagonists with good antinausea effects.
PMID 17587360·Eur J Cancer Care (Engl)·2007
8-other
Melanoma inhibition by cyclooxygenase inhibitors: role of interleukin-6 suppression, a putative mechanism of action, and clinical implications.
PMID 17673806·Med Oncol·2007
6-review
Some fibrocystic breast change may be caused by sexually transmitted H. pylori during oral nipple contact: supporting literature and case report of resolution after gut H. pylori eradication treatment.
PMID 17113238·Med Hypotheses·2007
5-case
Consideration of acamprosate for treatment of amyotrophic lateral sclerosis.
PMID 17368956·Med Hypotheses·2007
7-preclinical
Co-administration of ramelton and fluvoxamine to increase levels of interleukin-2.
PMID 16893613·Med Hypotheses·2006
8-other
Aspirin, TNF-alpha, NFkB, and survival in multiple myeloma: the importance of measuring TNF-alpha.
PMID 17139447·Inflammopharmacology·2006
8-other
Evidence that amphotericin B mediates reactivation of latent Epstein-Barr virus in Hodgkin's lymphoma allowing cytotoxicity by acyclovir.
PMID 16642564·Yonsei Med J·2006
8-other
Proposal for using small molecule tumor necrosis factor-alpha lowering agents, possibly bupropion, in aplastic anemia.
PMID 15922115·Med Hypotheses·2005
8-other
Evidence of a mechanism by which etanercept increased TNF-alpha in multiple myeloma: new insights into the biology of TNF-alpha giving new treatment opportunities--the role of bupropion.
PMID 15964626·Leuk Res·2005
6-review
Tiagabine may reduce bruxism and associated temporomandibular joint pain.
PMID 16252740·Anesth Prog·2005
5-case
Combination of bupropion, paroxetine and quetiapine as adjuvant treatment for multiple myeloma.
PMID 15082113·Med Hypotheses·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 11 ARLINGTON CT
BURLINGTON, VT 05408 - Phone
- (802) 557-7278
Quick Facts
- NPI
- 1235233644
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile